Gastrointestinal Bleeding in Patients with SARS-CoV-2 Infection Managed by Interventional Radiology

Anna Maria Ierardi1, Andrea Coppola2, Silvia Tortora3

  • 1Radiology Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy.

Insights

Trans-arterial embolization (TAE) is a safe and effective treatment for gastrointestinal bleeding (GIB) in patients with Coronavirus Disease 2019 (COVID-19). This procedure demonstrated high technical and clinical success rates in the studied population.

Area of Science:

  • Interventional Radiology
  • Gastroenterology
  • Infectious Diseases

Background:

  • Gastrointestinal bleeding (GIB) is a serious complication in patients with Coronavirus Disease 2019 (COVID-19).
  • Understanding patient characteristics and risk factors associated with GIB in COVID-19 is crucial for effective management.

Purpose of the Study:

  • To evaluate the technical and clinical success of trans-arterial embolization (TAE) for treating GIB in COVID-19 patients.
  • To assess the safety profile of TAE in this specific patient cohort.
  • To describe the demographic and clinical characteristics of COVID-19 patients experiencing GIB.

Main Methods:

  • Retrospective analysis of 34 hospitalized COVID-19 patients with GIB.
  • Evaluation of patient risk factors, medications for COVID-19, and clinical/biological parameters.
  • Analysis of intraprocedural data and embolization outcomes.

Main Results:

  • GIB was more prevalent in males, with common comorbidities including overweight, hypertension, diabetes, and prior cardiac disease.
  • Many patients had Acute Respiratory Distress Syndrome (ARDS) and elevated D-dimer levels.
  • Trans-arterial embolization achieved high technical (88.2%) and clinical (94.1%) success rates with a low complication rate (5.9%).

Conclusions:

  • Trans-arterial embolization is a feasible, effective, and safe therapeutic option for managing gastrointestinal bleeding in COVID-19 patients.
  • The study identifies key characteristics of COVID-19 patients susceptible to GIB, aiding in early recognition and intervention.
Abstract

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
173
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
248
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
429
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
178
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
171
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
416